A rare case of sorafenib-induced severe hyponatremia

BACKGROUND: Sorafenib is an anti-angiogenic tyrosine kinase inhibitor used to treat patients with renal cell cancer and advanced hepatocellular cancer. Common adverse effects of sorafenib are rash, diarrhea, nausea, and abnormal liver function test and hand-foot syndrome. CASE PRESENTATION: Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaja, Misbahuddin, Torchon, Frantz, Millerman, Konstantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488774/
https://www.ncbi.nlm.nih.gov/pubmed/31065359
http://dx.doi.org/10.1177/2050313X19846048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6488774/
https://www.ncbi.nlm.nih.gov/pubmed/31065359
http://dx.doi.org/10.1177/2050313X19846048

Ejemplares similares